InvestorsHub Logo
Followers 58
Posts 10138
Boards Moderated 1
Alias Born 09/21/2016

Re: sokol post# 406600

Friday, 03/10/2023 10:02:38 AM

Friday, March 10, 2023 10:02:38 AM

Post# of 461943
Excellent work SOKOL

chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://79bcf7a1-8b8e-483b-b7cf-f5c5192a6d63.usrfiles.com/ugd/79bcf7_c5813c517d9f4ca5aacbeb719508827a.pdf
In other words, Blarcamesine restored dysregulated genes associated with Alzheimer's and Parkinson's. If so, was that restoration evident in all patients treated with Blarcamesine versus no restoration in the placebo patients? More importantly, did all treated patients show some degree of improvement or decline in the progression of the diseases? Or was it that the restoration occurred only in those patients treated with the Blarcamesine high dose?

It's all about connecting the right DOTS.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News